4th Quarter - Report

FABIANI & COMPANY for VARIATION BIOTECHNOLOGIES (US), INC.

Period 4th Quarter 2009 Filed Jan 20, 2010 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
VARIATION BIOTECHNOLOGIES (US), INC.
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Funding and parnerships with the Department of Defense and Department of Health and Human Services for vaccine research and development

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: Natl Institutes of Health (NIH); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Funding and parnerships with the Department of Defense and Department of Health and Human Services for vaccine research and development

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: Defense, Dept of (DOD); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Defense DEF

Funding and parnerships with the Department of Defense for vaccine research and development

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.